ReillyReynsKayserMD
Psychiatry • New York, NYMedical Director, Center for OCD and Related Disorders, Columbia University and New York State Psychiatric Institute
Dr. Kayser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1051 Riverside Drive
3100 Suite
New York, NY 10032- Is this information wrong?
Summary
- I am a psychiatrist and clinical researcher focused on identifying and testing novel therapeutic strategies to treat symptoms of obsessive-compulsive disorder (OCD) and anxiety. I am particularly interested in the brain’s endocannabinoid system, its role in the pathophysiology underlying OCD and anxiety disorders, and its potential as a treatment target for these conditions.
After graduating from Yale University with a BA in psychology/behavioral neuroscience, I obtained my medical degree from Georgetown University School of Medicine. I then completed residency in psychiatry and an NIMH T32 research fellowship in affective, anxiety, and related disorders at Columbia University Medical Center and New York State Psychiatric Institute.
I currently serve as Medical Director of the Center for OCD and Related Disorders, where I treat patients with OCD and anxiety disorders as a study psychiatrist, help to coordinate the Center’s various clinical research projects, and supervise research assistants, residents, and fellows.
Education & Training
New York-Presbyterian HospitalPost-Doctoral Fellowship, NIMH T32 Research Fellowship, 2018 - 2021- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 2014 - 2018
Georgetown University School of MedicineClass of 2014
Yale UniversityB.A., Psychology/Behavioral Neuroscience, 2004 - 2008
Certifications & Licensure
NY State Medical License 2015 - 2024- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder Start of enrollment: 2022 Mar 01
Publications & Presentations
PubMed
- Pipeline in Jeopardy-Challenges in Developing Patient-Oriented Interventions Researchers in Psychiatry and Opportunities for Action.Reilly R Kayser, Melissa Arbuckle, H Blair Simpson> ;JAMA Psychiatry. 2022 Feb 1
- 6 citationsResilience predicts positive mental health outcomes during the COVID-19 pandemic in New Yorkers with and without obsessive-compulsive disorder.Dianne M Hezel, Amy M Rapp, Michael G Wheaton, Reilly R Kayser, Sarah V Rose, Gabrielle R Messner, Rachel Middleton, H Blair Simpson> ;Journal of Psychiatric Research. 2022 Jun 1
- 5 citationsPatterns of Cannabis Use Among Individuals with Obsessive-Compulsive Disorder: Results from an Internet Survey.Reilly R. Kayser, Meredith S Senter, Rebecca Tobet, Marissa Raskin, Sapana R. Patel, H. Blair Simpson> ;Journal of Obsessive-Compulsive and Related Disorders. 2021 Jul 1
- Join now to see all
Books/Book Chapters
Press Mentions
Cannabis Hyperemesis Syndrome: 5 Scientific Answers to "Scromiting" QuestionsAugust 5th, 2021- Can CBD Help OCD??February 5th, 2021
Cannabinoids Could Help Treat OCD, Researchers SuggestAugust 21st, 2019- Join now to see all
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
New York-Presbyterian/Hudson Valley HospitalCortlandt Manor, New York- New York State Psychiatric InstituteNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
